I agree that this site is using cookies. You can find further informations here.
X
Pett, SL
37  results:
Search for persons X
?
1

Tolerability of four‐drug antiretroviral combination therap..:

Burns, JE ; Stöhr, W ; Kinloch‐De Loes, S...
HIV Medicine.  22 (2021)  8 - p. 770-774 , 2021
Link: https://doi.org/10.1111/..
 
?
2

Week 96 results of the randomized, multicentre Maraviroc Sw..:

Pett, SL ; Amin, J ; Horban, A...
HIV Medicine.  19 (2017)  1 - p. 65-71 , 2017
Link: https://doi.org/10.1111/..
 
?
3

Predictors of bacterial pneumonia in Evaluation of Subcutan..:

Pett, SL ; Carey, C ; Lin, E...
HIV Medicine.  12 (2010)  4 - p. 219-227 , 2010
Link: https://doi.org/10.1111/..
 
?
4

Changes in CCR5+ cells and antigen-specific CD4+ T-cells du..:

Pett, SL ; Zaunders, J ; Bailey, M...
Journal of the International AIDS Society.  11 (2008)  S1 - p. , 2008
Link: https://doi.org/10.1186/..
 
?
5

Hepatic steatosis in people older and younger than fifty wh..:

Arenas-Pinto, A ; Bakewell, N ; Milinkovic, A...
https://discovery.ucl.ac.uk/id/eprint/10176968/2/Arenas-Pinto_HIV%20Medicine%20-%202023%20-%20Arenas%E2%80%90Pinto.pdf.  , 2023
Link: https://discovery.ucl.ac..
 
?
6

Utility of a buccal swab point-of-care test for the IFNL4 g..:

Sy, A ; McCabe, L ; Hudson, E...
doi:10.1371/journal.pone.0280551.  , 2023
Link: https://doi.org/10.1371/..
 
?
7

No overall impact on rate of weight gain with integrase inh..:

Burns, JE ; Stirrup, O ; Waters, L...
https://discovery.ucl.ac.uk/id/eprint/10136819/1/Stirrup_No%20overall%20impact%20on%20rate%20of%20weight%20gain%20with%20integrase%20inhibitor-containing%20regimens%20in%20antiretroviral-nai%CC%88ve%20adults_AAM.pdf.  , 2022
Link: https://discovery.ucl.ac..
 
?
8

Tolerability of four-drug antiretroviral combination therap..:

Burns, JE ; Stöhr, W ; Kinloch-De Loes, S...
https://discovery.ucl.ac.uk/id/eprint/10127543/16/Stohr_HIV%20Medicine%20-%202021%20-%20Burns%20-%20Tolerability%20of%20four%E2%80%90drug%20antiretroviral%20combination%20therapy%20in%20primary%20HIV%E2%80%901%20infection.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
9

High cure rates for HCV genotype 6 in advanced liver fibros..:

Flower, B ; McCabe, L ; Ngoc, CL...
doi:10.1093/ofid/ofab267.  , 2021
Link: https://doi.org/10.1093/..
 
?
10

Variable short duration treatment versus standard treatment..:

Cooke, GS ; Pett, SL ; McCabe, L...
doi:10.3310/eme08170.  , 2021
Link: https://doi.org/10.3310/..
 
?
11

Tolerability of four‐drug antiretroviral combination therap..:

Burns, JE ; Stöhr, W ; Kinloch‐De Loes, S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612356/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfecti..:

Hung, R ; Patel, N ; Fox, J...
https://discovery.ucl.ac.uk/id/eprint/10127261/1/Prevalence_of_HIV_hepatitis_B_and_HIV_hepatitis_C.96416.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
13

High cure rates for HCV genotype 6 in advanced liver fibros..:

Flower, B ; McCabe, L ; Ngoc, CL...
https://discovery.ucl.ac.uk/id/eprint/10127640/1/Cooke_ofab267.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
14

Benefits of enhanced infection prophylaxis at antiretrovira..:

Pett, SL ; Spyer, M ; Haddow, L...
https://discovery.ucl.ac.uk/id/eprint/10096689/1/Walker_Benefits%20of%20enhanced%20infection%20prophylaxis%20at%20antiretroviral%20therapy%20initiation%20by%20cryptococcal%20antigen%20status_AAM2.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
15

Variable short duration treatment versus standard treatment..:

Cooke, GS ; Pett, SL ; McCabe, L...
https://discovery.ucl.ac.uk/id/eprint/10137476/3/3037893.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
1-15